2015
DOI: 10.1056/nejmoa1408586
|View full text |Cite
|
Sign up to set email alerts
|

Mass Treatment with Single-Dose Azithromycin for Yaws

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

4
134
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 109 publications
(139 citation statements)
references
References 9 publications
4
134
1
Order By: Relevance
“…or Campylobacter spp. (Allos, 2001;Anonymous, 2013;Crameri & Heininger, 2008;Jimenez et al, 2015;Mitj a et al, 2015;Rolain et al, 2004;Ruiz et al, 2007;Stoner, 2007;Zuckerman, 2004), and have shown activity against some protozoa such as Plasmodium spp. or Toxoplasma gondii (Lee et al, 2011;Pereira et al, 2011).…”
Section: Clinical Usementioning
confidence: 99%
See 1 more Smart Citation
“…or Campylobacter spp. (Allos, 2001;Anonymous, 2013;Crameri & Heininger, 2008;Jimenez et al, 2015;Mitj a et al, 2015;Rolain et al, 2004;Ruiz et al, 2007;Stoner, 2007;Zuckerman, 2004), and have shown activity against some protozoa such as Plasmodium spp. or Toxoplasma gondii (Lee et al, 2011;Pereira et al, 2011).…”
Section: Clinical Usementioning
confidence: 99%
“…Recently the use of azithromycin in mass treatment to eradicate either trachoma or yaws has been proposed and evaluated (Jimenez et al, 2015;Mitj a et al, 2015). Interestingly, in a clinical trial on the eradication of trachoma developed in Ethiopia it was observed that the survival rate of children in the azithromycin arm was better than that of children receiving a placebo (Keenan et al, 2011).…”
Section: Clinical Usementioning
confidence: 99%
“…However, there is still a need to integrate health service provisions across the district to meet future demands. 13 For more information on recent health programs see and Mitjà et al (2011Mitjà et al ( , 2012Mitjà et al ( , 2013Mitjà et al ( , 2015.…”
mentioning
confidence: 99%
“…In 2015, a total of 65,000 cases were reported through 13 countries, [5] with 85% of them happening in Ghana, Papua New Guinea, and Solomon Islands [6]. However, the exact prevalence and burden of the disease remains unclear due to various factors, including low completeness/timeliness of reporting, the inconsistent reporting of cases across countries because of the status of non-noti iable disease, misdiagnosis, and lack of accuracy of data [7].…”
mentioning
confidence: 99%